Skip to content

Adient

US · ADNT #3061 by market cap Listed 2016
14.48 -0.60 -3.98%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Adient (ADNT) Gets a Buy From J.P. Morgan
    TipRanks · 2026/10/3
  • Rating change
    Citi Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29
    Market Newswire · 2026/8/11
  • A Quick Look at Today's Ratings for Adient(ADNT.US), With a Forecast Between $22 to $23
    Market Newswire · 2026/11/6
  • Rating change
    Barclays Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $25
    Market Newswire · 2026/8/10
  • Rating change
    Morgan Stanley Maintains Adient(ADNT.US) With Hold Rating, Raises Target Price to $21
    Market Newswire · 2026/8/18
  • Rating change
    J.P. Morgan Upgrades Adient(ADNT.US) to Buy Rating, Cuts Target Price to $25
    Market Newswire · 2026/9/15
  • Rating change
    Stifel Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $21
    Market Newswire · 2026/10/19
  • Rating change
    J.P. Morgan Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $25
    Market Newswire · 2026/10/3
  • Citi Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $27
    Market Newswire · 2026/11/6
  • Morgan Stanley Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $19
    Market Newswire · 2026/11/6
  • Rating change
    UBS Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $23
    Market Newswire · 2026/10/7
  • Rating change
    A Quick Look at Today's Ratings for Adient(ADNT.US), With a Forecast Between $26 to $29
    Market Newswire · 2026/8/7
  • Rating change
    UBS Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29
    Market Newswire · 2026/8/6
  • Rating change
    Barclays Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $22
    Market Newswire · 2026/10/9
  • Rating change
    Stifel Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $26
    Market Newswire · 2026/8/6
  • Rating change
    Wells Fargo Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $29
    Market Newswire · 2026/8/6
  • Rating change
    J.P. Morgan Initiates Adient(ADNT.US) With Hold Rating, Announces Target Price $28
    Market Newswire · 2026/8/10
  • Rating change
    Adient (ADNT) Was Upgraded to a Buy Rating at J.P. Morgan
    TipRanks · 2026/9/15
  • Barclays Maintains Adient(ADNT.US) With Hold Rating, Maintains Target Price $22
    Market Newswire · 2026/11/7
  • J.P. Morgan Maintains Adient(ADNT.US) With Buy Rating, Maintains Target Price $23
    Market Newswire · 2026/11/10
  • Rating change
    BNP Paribas Initiates Adient(ADNT.US) With Buy Rating, Announces Target Price $26
    Market Newswire · 2026/7/30
  • Rating change
    Stifel Maintains Adient(ADNT.US) With Buy Rating, Cuts Target Price to $26
    Market Newswire · 2026/7/20
  • Rating change
    J.P. Morgan Remains a Hold on Adient (ADNT)
    TipRanks · 2026/7/12
  • Rating change
    UBS Maintains Adient(ADNT.US) With Buy Rating, Raises Target Price to $34
    Market Newswire · 2026/7/9
  • Rating change
    BofA Securities Maintains Adient(ADNT.US) With Sell Rating
    Market Newswire · 2026/7/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Adient discussion 0 comments

Add a comment